[The use of bioregulator of the cytomedine class--epitalamin--in the treatment of combined craniocerebral trauma].

Anesteziologiia i reanimatologiia2004PMID: 15314861

Clinical TrialEpitalon

Plain Language Summary

Epithalamin (referred to as epitalamin in this study) was investigated as a treatment for combined craniocerebral trauma, which impairs the brain's ability to regulate neurohumoral metabolic processes. The use of this pineal peptide bioregulator represents a promising approach for treating this type of injury.

Abstract

The combined craniocerebral trauma is accompanied by an impaired brain function in respect to regulating the entire organism and extends the neurohumoral processes of metabolism. The use of a bioregulator of the cytomedine class--epitalamin--is an actual trend in the treatment of the above pathology.

Authors

Lebedeva, E A; Zavarzina, P Zh; Nemkova, Z A